Glucagon-like peptide-1 receptor agonists (GLP-1 ... differences between them. GLP-1 RAs are classified as short-acting or long-acting, depending on how long they work in your body.

They have been called miraculous and the fastest way to lose weight. From Wegovy to Mounjaro, here’s how GLP-1 drugs work ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...

They do this by mimicking a hormone called glucagon-like peptide 1, or GLP-1. GLP-1 binds to receptors in the pancreas ... for more on how GLP-1 agonists work.

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes ...

For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased risk for psychiatric adverse events or worsening ...

The popularity of GLP-1 receptor agonists have prompted some trainers to offer regimens that ... More specifically deal with the side effects of the resulting rapid weight loss. Here personal ...